Fundraising FoxPronutria Biosciences
Cambridge, US · Delaware corporation · 4 known investors
Find your way into Pronutria Biosciences
Sign up to find every way you can get introduced to Pronutria Biosciences
- Your email: who you already know at Pronutria Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pronutria Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
RC
Robert ConnellyExecutive
GM
Garry MenzelExecutive
JM
Jeff MooreExecutive
Board
JM
John MendleinBoard director
DB
NA
PB
Peter Barton HuttBoard director
CC
Charles CooneyBoard director
GB
Gregory BeharBoard director
SH
Stephen HogeBoard director
CV
Chris ViehbacherBoard director
GP
Gary PisanoBoard director
Investors · 4
Fidelity InvestmentsreportedBoston
How we know: funding news · Not right? Tell us
Flagship PioneeringinferredCambridge · $500K – $10Mvia Noubar Afeyan · board
How we know: board seat on SEC Form D · Not right? Tell us
Flagship VenturesreportedCambridge
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$92.8M disclosed across 3 rounds · 2015–2022
▶$6MraisedSep 2022 · 2 investors · BiotechnologyRule 506(b)
▶$6MraisedSep 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William HinshawExecutive Officer, Director
- Paul SekhriDirector
- Martin HendrixDirector
- Cristina M. RondinoneDirector
- Margaret KozielExecutive Officer
- Virginia DeanExecutive Officer
- Gary PisanoDirector
- David R. EpsteinDirector
- Robert CraneExecutive Officer
- Catherine A. SohnDirector
- William D. BairdDirector
- Paul FehlnerExecutive Officer
- Michael RosenblattDirector
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$42.5MraisedFeb 2017 · 1 investors · BiotechnologyRule 506(b)
▶$42.5MraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert ConnellyExecutive Officer, Director
- John MendleinDirector
- Peter Barton HuttDirector
- Noubar AfeyanDirector
- Stephen HogeDirector
- Gary PisanoDirector
- Charles CooneyDirector
- Gregory BeharDirector
- Chris ViehbacherDirector
- David BerryDirector
- Jeff MooreExecutive Officer
- Amount sold
- $42.5M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$44.3MraisedFeb 2016 · 12 investors · BiotechnologyRule 506(b)
▶$44.3MraisedFeb 2016 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert ConnellyExecutive Officer, Director
- Garry MenzelExecutive Officer
- John MendleinDirector
- Peter Barton HuttDirector
- David BerryDirector
- Jeff MooreExecutive Officer
- Charles CooneyDirector
- Gregory BeharDirector
- Stephen HogeDirector
- Noubar AfeyanDirector
- Chris ViehbacherDirector
- Gary PisanoDirector
- Amount sold
- $44.3M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pronutria Biosciences's investors?
- Pronutria Biosciences's investors include Fidelity Investments, Flagship Pioneering, Flagship Ventures, Syncona.
- How much funding has Pronutria Biosciences raised?
- Pronutria Biosciences has disclosed $92.8M raised across 3 rounds.
- Where is Pronutria Biosciences headquartered?
- Pronutria Biosciences is headquartered in Cambridge, US.